ArticleRevista brasileira de hematologia e hemoterapia2011
Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance.
Belinda Pinto Simões et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.